Single-use duodenoscopes and duodenoscopes with disposable end caps.

Cholangiopancreatography, Endoscopic Retrograde / adverse effects Cross Infection / prevention & control Disease Outbreaks Disinfection Duodenoscopes Equipment Contamination / prevention & control Humans

Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
05 2021
Historique:
received: 14 12 2020
accepted: 14 12 2020
pubmed: 14 3 2021
medline: 3 6 2021
entrez: 13 3 2021
Statut: ppublish

Résumé

Multidrug-resistant infectious outbreaks associated with duodenoscopes have been documented internationally. Single-use duodenoscopes, disposable distal ends, or distal end cap sealants could eliminate or reduce exogenous patient-to-patient infection associated with ERCP. This document reviews technologies that have been developed to help reduce or eliminate exogenous infections because of duodenoscopes. Four duodenoscopes with disposable end caps, 1 end sheath, and 2 disposable duodenoscopes are reviewed in this document. The evidence regarding their efficacy in procedural success rates, reduction of duodenoscope bacterial contamination, clinical outcomes associated with these devices, safety, and the financial considerations are discussed. Several technologies discussed in this document are anticipated to eliminate or reduce exogenous infections during endoscopy requiring a duodenoscope. Although disposable duodenoscopes can eliminate exogenous ERCP-related risk of infection, data regarding effectiveness are needed outside of expert centers. Additionally, with more widespread adoption of these new technologies, more data regarding functionality, medical economics, and environmental impact will accrue. Disposable distal end caps facilitate duodenoscope reprocessing; postmarketing surveillance culture studies and real-life patient infection analyses are important areas of future research.

Sections du résumé

BACKGROUND AND AIMS
Multidrug-resistant infectious outbreaks associated with duodenoscopes have been documented internationally. Single-use duodenoscopes, disposable distal ends, or distal end cap sealants could eliminate or reduce exogenous patient-to-patient infection associated with ERCP.
METHODS
This document reviews technologies that have been developed to help reduce or eliminate exogenous infections because of duodenoscopes.
RESULTS
Four duodenoscopes with disposable end caps, 1 end sheath, and 2 disposable duodenoscopes are reviewed in this document. The evidence regarding their efficacy in procedural success rates, reduction of duodenoscope bacterial contamination, clinical outcomes associated with these devices, safety, and the financial considerations are discussed.
CONCLUSIONS
Several technologies discussed in this document are anticipated to eliminate or reduce exogenous infections during endoscopy requiring a duodenoscope. Although disposable duodenoscopes can eliminate exogenous ERCP-related risk of infection, data regarding effectiveness are needed outside of expert centers. Additionally, with more widespread adoption of these new technologies, more data regarding functionality, medical economics, and environmental impact will accrue. Disposable distal end caps facilitate duodenoscope reprocessing; postmarketing surveillance culture studies and real-life patient infection analyses are important areas of future research.

Identifiants

DOI: 10.1016/j.gie.2020.12.033 PMID: 33712228
pubmed: 33712228
pii: S0016-5107(20)35112-9
doi: 10.1016/j.gie.2020.12.033
pii:
doi:

Types de publication

Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

997-1005

Informations de copyright

Copyright © 2021 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Auteurs

Arvind J Trindade (AJ)

Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Medical Center, New Hyde Park, New York, USA.

Andrew Copland (A)

Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.

Amit Bhatt (A)

Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, Ohio, USA.

Juan Carlos Bucobo (JC)

Department of Gastroenterology, Stony Brook Medicine, Stony Brook, New York, USA.

Vinay Chandrasekhara (V)

Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Kumar Krishnan (K)

Division of Gastroenterology, Department of Internal Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, USA.

Mansour A Parsi (MA)

Section for Gastroenterology and Hepatology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.

Nikhil Kumta (N)

Division of Gastroenterology, Mount Sinai Hospital, New York, New York, USA.

Ryan Law (R)

Department of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA.

Rahul Pannala (R)

Department of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA.

Erik F Rahimi (EF)

Department of Gastroenterology, Baylor Scott & White Health, Lakeway, Texas, USA.

Monica Saumoy (M)

Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Guru Trikudanathan (G)

Department of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA.

Julie Yang (J)

Division of Gastroenterology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.

David R Lichtenstein (DR)

Division of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Procédures de chirurgie opératoire › Interventions chirurgicales mini-invasives › Endoscopie › Endoscopie digestive › Cholangiopancréatographie rétrograde endoscopique › Single-use duodenoscopes and duodenoscopes...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie iatrogène › Infection croisée › Single-use duodenoscopes and duodenoscopes...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Single-use duodenoscopes and duodenoscopes...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Contrôle des maladies transmissibles › Prévention des infections › Stérilisation › Désinfection › Single-use duodenoscopes and duodenoscopes...
questionsmedicales.fr › Équipement et fournitures › Équipement chirurgical › Endoscopes › Endoscopes gastrointestinaux › Duodénoscopes › Single-use duodenoscopes and duodenoscopes...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Contamination de matériel › Single-use duodenoscopes and duodenoscopes...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Single-use duodenoscopes and duodenoscopes...